This is a Validated Antibody Database (VAD) review about human HLA-DR, based on 366 published articles (read how Labome selects the articles), using HLA-DR antibody in all methods. It is aimed to help Labome visitors find the most suited HLA-DR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA-DR synonym: HLA-DRA1
BioLegend
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307606) was used in flow cytometry on human samples (fig s1b). Stem Cell Res Ther (2022) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . J Exp Med (2022) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig e9a). Nature (2022) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307609) was used in flow cytometry on human samples at 1:100 (fig 6b, s26). Nat Nanotechnol (2022) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:300 (fig 6b). Nat Commun (2021) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . Immunity (2021) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307632) was used in flow cytometry on mouse samples . J Autoimmun (2021) ncbi |
| mouse monoclonal (LN3) |
| BioLegend HLA-DR antibody (Biolegend, 327007) was used in flow cytometry on human samples (fig 4d). Oncogene (2021) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig s3c). Cell (2021) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). J Immunother Cancer (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307638) was used in flow cytometry on human samples (fig 2e). Cell (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1c). BMC Cancer (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi |
| mouse monoclonal (TU36) |
| BioLegend HLA-DR antibody (Biolegend, 361607) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307642) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig 6b). Cell Rep (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307629) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307619) was used in flow cytometry on human samples at 1:50 (fig e4f). Nature (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples . JCI Insight (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307642) was used in flow cytometry on human samples (fig 2d). Immunity (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 8a). elife (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307626) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307603) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi |
| mouse monoclonal (Tu39) |
| BioLegend HLA-DR antibody (Biolegend, 361702) was used in blocking or activating experiments on human samples at 20 ug/ml (fig s3i). Cancer Cell (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307659) was used in other on human samples (fig 4b). Cell (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). JCI Insight (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307602) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307650) was used in flow cytometry on human samples at 1:100 (fig s1c, s3a). Cancer Cell (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307623) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi |
| mouse monoclonal (LN3) |
| BioLegend HLA-DR antibody (Biolegend, 327014) was used in flow cytometry on human samples (fig 3g). Science (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307610) was used in flow cytometry on human samples at 1:1 (fig 5a). Nat Commun (2019) ncbi |
| mouse monoclonal (LN3) |
| BioLegend HLA-DR antibody (Biolegend, LN3) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307618) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2019) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307618) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c). J Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). Nucleic Acids Res (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, H243) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend HLA-DR antibody (BioLegend, L243) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi |
| mouse monoclonal (L243) |
| In order to define the transcriptional network specifies conferring microglia identity, BioLegend HLA-DR antibody (BioLegend, 307616) was used in flow cytometry on human samples at 1:50. Science (2017) ncbi |
| mouse monoclonal (L243) |
| In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend HLA-DR antibody (biolegend, L243) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi |
| mouse monoclonal (L243) |
| In order to map the lineage of human dendritic cells, BioLegend HLA-DR antibody (Biolegend, L243) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi |
| mouse monoclonal (L243) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2e). Oncoimmunology (2017) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples at 1:200 (fig s1d). Nat Commun (2017) ncbi |
| mouse monoclonal (L243) |
| In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi |
| mouse monoclonal (L243) |
| In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi |
| mouse monoclonal (L243) |
| In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Oncotarget (2016) ncbi |
| mouse monoclonal (L243) |
| In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples . J Exp Med (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, 307606) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi |
| mouse monoclonal (L243) |
| In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to identify peanut proteins that can predict peanut allergy., BioLegend HLA-DR antibody (Biolegend, 307624) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to elucidate the mechanisms by which DRibbles induce T-cell activation, BioLegend HLA-DR antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi |
| mouse monoclonal (LN3) |
| In order to assess how spore movement of Bacillus anthracis does not require a carrier cell and is not affected by lethal toxin in human lung models, BioLegend HLA-DR antibody (Biolegend, 327002) was used in immunocytochemistry on human samples at 0.5 ug/ml (fig 1). Microbes Infect (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 7a). J Biol Chem (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi |
| mouse monoclonal (LN3) |
| BioLegend HLA-DR antibody (BioLegend, LN3) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi |
| mouse monoclonal (Tu39) |
| BioLegend HLA-DR antibody (BioLegend, Tu39) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi |
| mouse monoclonal (LN3) |
| BioLegend HLA-DR antibody (Biolegend, LN3) was used in flow cytometry on human samples at 1:400 (fig 2). PLoS ONE (2016) ncbi |
| mouse monoclonal (L243) |
| In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend HLA-DR antibody (Biolegend, 307616) was used in flow cytometry on human samples at 1:200 (fig s1a). Acta Neuropathol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). Oncotarget (2016) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi |
| mouse monoclonal (L243) |
| In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend HLA-DR antibody (BioLegend, L243) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi |
| mouse monoclonal (L243) |
| In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend HLA-DR antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi |
| mouse monoclonal (LN3) |
| In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend HLA-DR antibody (Biolegend, clone LN3) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi |
| mouse monoclonal (L243) |
| In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend HLA-DR antibody (Biolegend, 307604) was used in flow cytometry on human samples . Cytometry A (2015) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend HLA-DR antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi |
| mouse monoclonal (L243) |
| In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi |
| mouse monoclonal (Tu39) |
| BioLegend HLA-DR antibody (Biolegend, #361703) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi |
| mouse monoclonal (L243) |
| In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend HLA-DR antibody (Biolegend, 307617) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L432) was used in blocking or activating experiments on human samples at 15 ug/ml (fig 4). Vaccine (2015) ncbi |
| mouse monoclonal (L243) |
| In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend HLA-DR antibody (BioLegend, clone L243) was used in flow cytometry on human samples . Chest (2015) ncbi |
| mouse monoclonal (L243) |
| In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi |
| mouse monoclonal (L243) |
| In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (BioLegend, L243) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi |
| mouse monoclonal (L243) |
| In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend HLA-DR antibody (Biolegend, 307604) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi |
| mouse monoclonal (L243) |
| In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . Blood (2014) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples . Front Immunol (2014) ncbi |
| mouse monoclonal (L243) |
| BioLegend HLA-DR antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 6b). J Immunol (2014) ncbi |
| mouse monoclonal (L243) | In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend HLA-DR antibody (Biolegend, L243) was used . J Immunol (2014) ncbi | |
| mouse monoclonal (L243) |
| In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BioLegend HLA-DR antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig 5A). J Immunol (2014) ncbi |
Invitrogen
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (Invitrogen, 14-9956-82) was used in immunohistochemistry on mouse samples at 1:200 (fig s3). Mol Neurodegener (2021) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (Invitrogen, 47-9956-41) was used in flow cytometry on human samples (fig 1b). Stem Cell Res Ther (2021) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 25-9956-42) was used in flow cytometry on human samples at 1:100 (fig s3e). Immunity (2021) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 14-9956-82) was used in immunohistochemistry on mouse samples at 1:750. Acta Neuropathol Commun (2021) ncbi |
| mouse monoclonal (LN3) | Invitrogen HLA-DR antibody (ThermoFisher, 14-9956-82) was used . Antioxidants (Basel) (2021) ncbi | |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 14-9956) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2-a3). Cells (2020) ncbi |
| mouse monoclonal (TU36) |
| Invitrogen HLA-DR antibody (Thermofisher, Q22158) was used in flow cytometry on human samples (fig 3b). elife (2020) ncbi |
| mouse monoclonal (TU36) |
| Invitrogen HLA-DR antibody (Invitrogen, Tu36) was used in mass cytometry on human samples (fig 2b, 2s8a). elife (2020) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in immunohistochemistry on mouse samples (fig 1). JCI Insight (2019) ncbi |
| mouse monoclonal (LN-3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in immunohistochemistry on mouse samples (fig 1). JCI Insight (2019) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (Ebioscience, 47-9956-42) was used in flow cytometry on human samples (fig 6c). Oncoimmunology (2019) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 12-9956-42) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi |
| mouse monoclonal (L243) |
| Invitrogen HLA-DR antibody (eBioscience, 11-9952-41) was used in flow cytometry on human samples (fig 3c). Cell (2019) ncbi |
| mouse monoclonal (L243) |
| Invitrogen HLA-DR antibody (eBioscience, L243) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 14-99-56-82) was used in immunohistochemistry on human samples at 1:1000 (fig 2f). Clin Exp Immunol (2018) ncbi |
| mouse monoclonal (LN-3) |
| In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi |
| mouse monoclonal (MEM-267) |
| In order to report the effects of long-term lipopolysaccharide exposure on monocytes, Invitrogen HLA-DR antibody (Thermo Fischer Scientific, MA1-19393) was used in western blot on human samples (fig 3d). Toxicol In Vitro (2017) ncbi |
| mouse monoclonal (LN-3) |
| In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 5a). Stem Cells (2017) ncbi |
| mouse monoclonal (LN3) |
| In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 5a). Stem Cells (2017) ncbi |
| mouse monoclonal (L243) |
| In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, Invitrogen HLA-DR antibody (Fisher Scientific, L243) was used in flow cytometry on rhesus macaque samples (fig 1a). J Immunol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to study the restoration of immune function in chronic HIV infection, Invitrogen HLA-DR antibody (eBioscience, L240) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2017) ncbi |
| mouse monoclonal (LN-3) |
| In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen HLA-DR antibody (Invitrogen, MHLDR31) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to perform a Cytometry by Time-Of-Flight analysis on primary airway samples obtained from well-characterized patients with asthma and cystic fibrosis, Invitrogen HLA-DR antibody (ThermoFisher Scientific, Q22158) was used in flow cytometry on human samples (fig s2). Cytometry B Clin Cytom (2017) ncbi |
| mouse monoclonal (L243) |
| In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, Invitrogen HLA-DR antibody (eBioscience, L243) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 11-9956) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi |
| rat monoclonal (YD1/63.4.10) |
| In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Invitrogen HLA-DR antibody (Thermo Fisher, MA1-70113) was used in flow cytometry on human samples (fig 4b). Nanomedicine (Lond) (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen HLA-DR antibody (Invitrogen, T-36) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 45-9956-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi |
| mouse monoclonal (LN3) |
| In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen HLA-DR antibody (Invitrogen, LN3) was used in flow cytometry on human samples (fig 2f). PLoS Pathog (2016) ncbi |
| mouse monoclonal (LN-3) |
| In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen HLA-DR antibody (Invitrogen, LN3) was used in flow cytometry on human samples (fig 2f). PLoS Pathog (2016) ncbi |
| mouse monoclonal (L243) |
| In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen HLA-DR antibody (ebioscience, L243) was used in flow cytometry on human samples at 1:50 (fig s2c). Nat Med (2016) ncbi |
| mouse monoclonal (L243) |
| In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen HLA-DR antibody (eBioscience, 12-9952-41) was used in flow cytometry on human samples at 1:20 (fig s5j). Nat Cell Biol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, Invitrogen HLA-DR antibody (eBiosciences, L243-ef450) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, Invitrogen HLA-DR antibody (Invitrogen, VXMHLDR17) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi |
| mouse monoclonal (LN-3) |
| In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on African green monkey samples . Infect Immun (2016) ncbi |
| mouse monoclonal (LN3) |
| In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on African green monkey samples . Infect Immun (2016) ncbi |
| mouse monoclonal (LN3) |
| In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi |
| mouse monoclonal (LN-3) |
| In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 12-9956-42) was used in flow cytometry on human samples at 1:200 (fig st3). Leukemia (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, Invitrogen HLA-DR antibody (Life Technologies, MHLDR17) was used in flow cytometry on rhesus macaque samples (fig 5). PLoS ONE (2015) ncbi |
| mouse monoclonal (LN3) |
| In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi |
| mouse monoclonal (LN-3) |
| In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples at 5:100 (fig s3). Nat Commun (2015) ncbi |
| mouse monoclonal (LN3) |
| In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples at 5:100 (fig s3). Nat Commun (2015) ncbi |
| mouse monoclonal (TU36) |
| In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen HLA-DR antibody (BD, MHLDR01) was used in flow cytometry on human samples . Cancer Res (2015) ncbi |
| mouse monoclonal (L243) |
| Invitrogen HLA-DR antibody (eBioscience, 25-9952-41) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi |
| mouse monoclonal (TU36) |
| In order to study the role of autophagy in melanoma, Invitrogen HLA-DR antibody (Life Technologies, MHLDR01) was used in flow cytometry on human samples . Biochem Pharmacol (2015) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, 11-9956) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi |
| mouse monoclonal (LN3) |
| In order to study the role of dendritic cells in relation to T cells, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (LN-3) |
| In order to discuss a meta-analysis of genome-wide association study data on Abeta1-42 and pTau181 in Alzheimer's disease dementia patients, Invitrogen HLA-DR antibody (Thermo, MA1-35420) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Hum Mol Genet (2014) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Exp Med (2014) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi |
| mouse monoclonal (LN3) |
| In order to analyze chronic lymphocytic leukemia and how cytokine-driven loss of plasmacytoid dendritic cell function occurs, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . Leukemia (2014) ncbi |
| mouse monoclonal (LN3) |
| Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi |
| mouse monoclonal (TU36) |
| In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen HLA-DR antibody (Invitrogen, Tu36) was used in flow cytometry on human samples at 1:20 (fig s6). Nat Med (2013) ncbi |
| mouse monoclonal (LN3) |
| In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3b). J Infect Dis (2014) ncbi |
| mouse monoclonal (LN-3) |
| In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen HLA-DR antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3b). J Infect Dis (2014) ncbi |
| mouse monoclonal (L243) |
| Invitrogen HLA-DR antibody (eBioscience, L243) was used in flow cytometry on human samples . J Hepatol (2014) ncbi |
| mouse monoclonal (TU36) |
| In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen HLA-DR antibody (Caltag Laboratories, clone Tu36) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi |
| mouse monoclonal (LN3) |
| In order to optimize rhesus monkey decellularized kidney scaffolds, Invitrogen HLA-DR antibody (Life Technologies, LN3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:50 (fig 2). PLoS ONE (2013) ncbi |
| mouse monoclonal (LN-3) |
| In order to optimize rhesus monkey decellularized kidney scaffolds, Invitrogen HLA-DR antibody (Life Technologies, LN3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:50 (fig 2). PLoS ONE (2013) ncbi |
| mouse monoclonal (TU36) |
| In order to test if vaccination alters the activation state of T cells within the gastrointestinal mucosa, inguinal lymph nodes, and peripheral blood, Invitrogen HLA-DR antibody (Invitrogen, TU36) was used in flow cytometry on rhesus macaque samples (fig 2a). Hum Vaccin Immunother (2012) ncbi |
| mouse monoclonal (TU36) |
| In order to study the diverse functions of li in DCs, Invitrogen HLA-DR antibody (Caltag Laboratories, MHLDR05) was used in flow cytometry on human samples . J Leukoc Biol (2012) ncbi |
| mouse monoclonal (L243) |
| In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen HLA-DR antibody (eBioscience, 48-9952-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi |
| mouse monoclonal (LN-3) |
| In order to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model, Invitrogen HLA-DR antibody (Zymed Laboratory, clone LN-3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (tbl 2) and in flow cytometry on rhesus macaque samples (fig 7). J Pathol (2008) ncbi |
| mouse monoclonal (LN3) |
| In order to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model, Invitrogen HLA-DR antibody (Zymed Laboratory, clone LN-3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (tbl 2) and in flow cytometry on rhesus macaque samples (fig 7). J Pathol (2008) ncbi |
| mouse monoclonal (TU36) |
| In order to describe a culture method for directed differentiation of human embryonic stem cells to dendritic cells, Invitrogen HLA-DR antibody (Caltag, MHLDR04) was used in flow cytometry on human samples at 1:50. Methods Mol Biol (2007) ncbi |
| mouse monoclonal (TU36) |
| In order to characterize the frequency of potential targets of HIV infection within the female reproductive tract, Invitrogen HLA-DR antibody (Caltag, MHLDR01) was used in immunohistochemistry on human samples (fig 2). Immunology (2004) ncbi |
| mouse monoclonal (TU36) |
| In order to study CD45 splice variants in patients with hemophagocytic lymphohistiocytosis, Invitrogen HLA-DR antibody (Caltag, TU36) was used in flow cytometry on human samples . Pediatr Res (2004) ncbi |
| mouse monoclonal (TU36) |
| In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen HLA-DR antibody (Caltag, TU36) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi |
| mouse monoclonal (TU36) |
| In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen HLA-DR antibody (Caltag, TU36) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi |
| mouse monoclonal (LN3) |
| In order to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation, Invitrogen HLA-DR antibody (Zymed, LN-3) was used in immunohistochemistry - frozen section on human samples (fig 6) and in flow cytometry on human samples (fig 4). Int Immunol (2002) ncbi |
| mouse monoclonal (LN-3) |
| In order to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation, Invitrogen HLA-DR antibody (Zymed, LN-3) was used in immunohistochemistry - frozen section on human samples (fig 6) and in flow cytometry on human samples (fig 4). Int Immunol (2002) ncbi |
| mouse monoclonal (TU36) |
| In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen HLA-DR antibody (Caltag, TU 36) was used in flow cytometry on human samples . Infect Immun (2000) ncbi |
| mouse monoclonal (TU36) |
| In order to report that the expression of CD41 and c-mpl were not predictive of commitment to the megakaryocyte lineage, Invitrogen HLA-DR antibody (Caltag, TU36) was used in flow cytometry on human samples . Br J Haematol (1999) ncbi |
| mouse monoclonal (TU36) |
| In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen HLA-DR antibody (Caltag, TU36) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi |
Abcam
| domestic rabbit monoclonal (EPR3692) |
| Abcam HLA-DR antibody (Abcam, ab92511) was used in immunohistochemistry on human samples at 1:50 (fig 4e). Front Immunol (2021) ncbi |
| mouse monoclonal (L243) |
| Abcam HLA-DR antibody (Abcam, ab136320) was used in flow cytometry on human samples (fig 3a). PLoS Pathog (2021) ncbi |
| domestic rabbit monoclonal (EPR3692) |
| Abcam HLA-DR antibody (Abcam, 92511) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6m). PLoS Genet (2021) ncbi |
| domestic rabbit monoclonal |
| Abcam HLA-DR antibody (Abcam, ab215312) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:500 (fig s8b). Science (2020) ncbi |
| domestic rabbit monoclonal (EPR3692) |
| Abcam HLA-DR antibody (Abcam, ab92511) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8a). J Exp Med (2020) ncbi |
| domestic rabbit monoclonal (EPR3692) |
| Abcam HLA-DR antibody (Abcam, ab92511) was used in immunocytochemistry on human samples (fig 2G). Reproduction (2016) ncbi |
| mouse monoclonal (LN3) |
| Abcam HLA-DR antibody (Abcam, ab95830) was used in flow cytometry on human samples . J Biol Chem (2013) ncbi |
Santa Cruz Biotechnology
| mouse monoclonal (TAL 1B5) |
| Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz Biotechnology, sc-53319) was used in western blot on human samples (fig 3a). Oncoimmunology (2018) ncbi |
| mouse monoclonal (DA6.147) |
| Santa Cruz Biotechnology HLA-DR antibody (SantaCruz, DA6.147) was used in western blot on human samples (fig 2a). Childs Nerv Syst (2017) ncbi |
| mouse monoclonal (ML11C11) |
| Santa Cruz Biotechnology HLA-DR antibody (santa Cruz, sc-73366) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi |
| mouse monoclonal (TAL 1B5) |
| Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz Biotechnology, sc-53319) was used in immunohistochemistry on human samples at 1:1000 (fig 3) and in western blot on human samples at 1:5000 (fig 2). Nat Commun (2016) ncbi |
| mouse monoclonal (CR3/43) |
| Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz Biotechnology, sc-53302) was used in immunohistochemistry on human samples at 1:1000 (fig s5). Nat Commun (2016) ncbi |
| rat monoclonal (ER-TR3) |
| Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz, sc-59318) was used in immunohistochemistry on mouse samples (fig 5). PLoS ONE (2015) ncbi |
| mouse monoclonal (TAL 1B5) |
| In order to describe the immune responses in the lungs of cats naturally infected with C. felis, Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz Biotechnology, TAL 1B5) was used in immunohistochemistry - paraffin section on cat samples . Vet Immunol Immunopathol (2015) ncbi |
| mouse monoclonal (520B) |
| Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz, sc-69673) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi |
| mouse monoclonal (TAL 1B5) |
| In order to characterize CD81(+) and CD63(+) subpopulations of exosomes released from B-cell lymphoma cell lines, Santa Cruz Biotechnology HLA-DR antibody (Santa Cruz, sc-53319) was used in western blot on human samples . Clin Ther (2014) ncbi |
Miltenyi Biotec
| human monoclonal (REA805) |
| Miltenyi Biotec HLA-DR antibody (Miltenyi Biotec, 130-122-299) was used in mass cytometry on human samples (fig s7f). Cell Rep (2022) ncbi |
| mouse monoclonal (AC122) |
| Miltenyi Biotec HLA-DR antibody (Miltenyi Biotec, AC122) was used in flow cytometry on human samples (fig 4c). Cell Death Dis (2019) ncbi |
Bio-Rad
| mouse monoclonal (HL-39) |
| In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, Bio-Rad HLA-DR antibody (serotec, MCA1879) was used in flow cytometry on human samples (fig 4f). Exp Gerontol (2014) ncbi |
Beckman Coulter
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman Coulter, immu-357) was used in flow cytometry on human samples at 1:10. elife (2020) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman, PN IM3635) was used in flow cytometry on human samples (fig 1b). BMC Infect Dis (2019) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman Coulter, IMMU-157) was used in flow cytometry on rhesus macaque samples (fig 1a). AIDS (2018) ncbi |
| mouse monoclonal (9-49) |
| In order to study the antigen presentation by HLA-DP84Gly through the class I antigen processing pathway, Beckman Coulter HLA-DR antibody (Beckman Coulter, 6604366) was used in flow cytometry on human samples at 1:500 (fig 1a). Nat Commun (2017) ncbi |
| mouse monoclonal (B8.12.2) |
| In order to investigate the impact of a cancer-specific MUC1 glycoform, Beckman Coulter HLA-DR antibody (Beckman Coulter, B8.12.2) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Immunol (2016) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman Coulter, A74781) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2016) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman-Coulter, Immu-357) was used in flow cytometry on common marmoset samples (fig 5a). J Virol (2016) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman, IM1639U) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi |
| mouse monoclonal (Immu-357) |
| In order to examine the mechanism of anti-alpha4 antibody treatment in monkeys, Beckman Coulter HLA-DR antibody (Beckman Coulter, Immu-357) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2014) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman-Coulter, Immu-357) was used in flow cytometry on rhesus macaque samples . J Infect Dis (2015) ncbi |
| mouse monoclonal (B8.12.2) |
| Beckman Coulter HLA-DR antibody (Beckman Coulter, IM0464) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi |
| mouse monoclonal (9-49) |
| In order to discuss available reagents for studying the neotropical primate squirrel monkey, Beckman Coulter HLA-DR antibody (Beckman, 9-49(I3)) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi |
| mouse monoclonal (Immu-357) |
| Beckman Coulter HLA-DR antibody (Beckman Coulter, 2659) was used in flow cytometry on human samples . J Immunol (2002) ncbi |
BD Biosciences
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, TU36) was used in flow cytometry on human samples (fig 2b). Oncoimmunology (2022) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig s3b). Front Immunol (2021) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, 564040) was used in flow cytometry on human samples (fig 3a). Immunity (2021) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555561) was used in flow cytometry on human samples (fig 1f). Cell Res (2020) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig 1a, 4b). Rheumatology (Oxford) (2020) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 335796) was used in flow cytometry on African green monkey samples (fig s3a). PLoS Pathog (2020) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, 555812) was used in flow cytometry on human samples (fig 5d). Front Immunol (2019) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Bioscience, L243) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig s5c). PLoS Pathog (2019) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 3a). Am J Respir Crit Care Med (2019) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on mouse samples . Nature (2019) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 564040) was used in flow cytometry on human samples (fig 6g). Cell (2019) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2019) ncbi |
| monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, 564516) was used in flow cytometry on human samples (fig 2a). J Exp Med (2018) ncbi |
| monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 655874) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s18d). Science (2018) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, L243) was used in flow cytometry on human samples (fig 6d). Front Immunol (2018) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD Biosciences, Tu39) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD PharMingen, 560943) was used in flow cytometry on human samples (fig 1d). J Exp Med (2018) ncbi |
| mouse monoclonal (L243) |
| In order to study the involvement of Notch signaling in NK cell lineage determination, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to study the effect off HIV 1 vaccination in HIV carriers, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s1a). Front Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 7). J Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 5c). J Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to evaluate the role of IL-32alpha in NK cell inhibition, BD Biosciences HLA-DR antibody (BD Biosciences, G46.6) was used in flow cytometry on human samples (fig 1c). J Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, BD Biosciences HLA-DR antibody (BD/Pharm, 555809) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi |
| mouse monoclonal (TU36) |
| In order to study the antigen presentation by HLA-DP84Gly through the class I antigen processing pathway, BD Biosciences HLA-DR antibody (BD Biosciences, 555561) was used in flow cytometry on human samples at 1:500 (fig s1b). Nat Commun (2017) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, L243) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the role of Vgamma9/Vdelta2 T cells in intestinal IL-22 production, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 2b). Nature (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 1e). J Immunol (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences HLA-DR antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 3a). J Leukoc Biol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 1c). Eur J Immunol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to find SNPs that modulate VSTM1 expression using a Chinese cohort, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig s4). Genome Med (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BD Biosciences HLA-DR antibody (BD Bioscience, 556643) was used in flow cytometry on human samples . Mol Cell (2017) ncbi |
| mouse monoclonal (L243) |
| In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BD Biosciences HLA-DR antibody (BD Bioscience, 641393) was used in flow cytometry on human samples . Mol Cell (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, 561224) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (Pharmingen, L243) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (fig 1a). JCI Insight (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences HLA-DR antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 6e). Sci Rep (2017) ncbi |
| mouse monoclonal (L243) |
| In order to ask if small particle aerosols of virus would penetrate the lower respiratory tract and blanket alveoli where target cells reside, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on crab eating macaque samples (fig 3d). J Immunol (2017) ncbi |
| mouse monoclonal (L243) |
| In order to assess the diagnostic value of myxovirus resistance A expression for dermatomyositis, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in immunohistochemistry on human samples at 1:500. Neurology (2017) ncbi |
| mouse monoclonal (L243) |
| In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555560) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 561224) was used in flow cytometry on human samples (tbl s2). Science (2016) ncbi |
| mouse monoclonal (L243) |
| In order to determine which cells express CD83, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig s1a). J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences HLA-DR antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi |
| mouse monoclonal (G46-6) |
| In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 560944) was used in flow cytometry on human samples (fig 1c). Mol Med Rep (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences HLA-DR antibody (BD Pharmingen, 552764) was used in flow cytometry on rhesus macaque samples (fig s11b). Science (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BD Biosciences HLA-DR antibody (BD, 560896) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences HLA-DR antibody (BD Biosciences, 561358) was used in flow cytometry on human samples (fig 1a, 1c). JCI Insight (2016) ncbi |
| mouse monoclonal (L243) |
| In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences HLA-DR antibody (BD Biosciences, 641393) was used in flow cytometry on human samples (fig 1a, 1c). JCI Insight (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4b). Oncotarget (2016) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD PharMingen, 555558) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 6a). J Virol (2016) ncbi |
| mouse monoclonal (L243) |
| In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences HLA-DR antibody (BD Biosciences, 335813) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences HLA-DR antibody (BD PharMingen, 555812) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to identify cells that respond to interferon lambda, BD Biosciences HLA-DR antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 3a). J Interferon Cytokine Res (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 560896) was used in flow cytometry on human samples at 1:1000. Oncol Lett (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s1e). Sci Rep (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Bioscience, L243) was used in flow cytometry on human samples (fig 6b). Sci Rep (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (Becton Dickinson, L243) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig s4b). J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 556644) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 335813) was used in flow cytometry on human samples . Oncol Lett (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, 340688) was used in immunohistochemistry on human samples at 1:50 (fig 7b). J Clin Invest (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 2). Cytotherapy (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 3b). J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 1). J Transl Med (2016) ncbi |
| mouse monoclonal (L243) |
| In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences HLA-DR antibody (BD, L 243) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences HLA-DR antibody (BD Pharmingen, TU36) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to find that coagulation factor XII modulates immune responses, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:200 (fig 7j). Nat Commun (2016) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555558) was used in flow cytometry on human samples at 1:200 (fig 1). Oncoimmunology (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD PharMingen, 561224) was used in flow cytometry on human samples at 1:100 (fig 5). Oncoimmunology (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 7a). PLoS ONE (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BD Biosciences HLA-DR antibody (BD Biosciences, 559866) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555811) was used in flow cytometry on human samples (fig 1). Int J Mol Med (2016) ncbi |
| mouse monoclonal (TU36) |
| In order to find cell-surface markers specific to human neutrophils, BD Biosciences HLA-DR antibody (BD, 555561) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, 347364) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (Becton Dickinson-Pharmingen, LD43) was used in flow cytometry on human samples (fig 5b). Cell Immunol (2016) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD Bioscience, TU36) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences Pharmingen, L243) was used in flow cytometry on rhesus macaque samples (fig s2). Mucosal Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Horizon, G46-6) was used in flow cytometry on human samples at 1:40 (fig 2). Nat Commun (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi |
| mouse monoclonal (L243) |
| In order to characterize GS-9620-dependent TLR7 activation and the associated molecular determinants, BD Biosciences HLA-DR antibody (BD Biosciences, 641393) was used in flow cytometry on human samples (fig s7). PLoS ONE (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig S1A). J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, 560943) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2016) ncbi |
| mouse monoclonal (L243) |
| In order to determine support for heparin-free mesenchymal stem cell propagation in human platelet lysate by mechanical fibrinogen-depletion, BD Biosciences HLA-DR antibody (Becton Dickinson, L243) was used in flow cytometry on human samples (tbl 1). J Transl Med (2015) ncbi |
| mouse monoclonal (L243) |
| In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2015) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD Biosciences, TU36) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi |
| mouse monoclonal (L243) |
| In order to describe a selective CD28 antagonist for treatment of rheumatoid arthritis, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on rhesus macaque samples . Clin Exp Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, 340691) was used in flow cytometry on human samples (fig 4). Nat Commun (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, BD Biosciences HLA-DR antibody (BD, 552764) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2015) ncbi |
| mouse monoclonal (G46-6) |
| In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2i). J Immunol (2015) ncbi |
| mouse monoclonal (G46-6) |
| In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on mouse samples (fig s2d). Nat Chem Biol (2015) ncbi |
| mouse monoclonal (G46-6) |
| In order to discuss the importance of IL-5 positive Th2 cells to allergies, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig e4b). J Allergy Clin Immunol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences,, 555810) was used in flow cytometry on cat samples at 1:50 (tbl 3). Cell Reprogram (2015) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (BD bioscience, 555561) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi |
| mouse monoclonal (L243) |
| In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 560652) was used in flow cytometry on human samples (fig 2). Stem Cell Res Ther (2015) ncbi |
| mouse monoclonal (L243) |
| In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on marmosets samples . J Neuroimmune Pharmacol (2016) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 561224) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555810) was used in flow cytometry on human samples (fig 2). Int J Mol Med (2015) ncbi |
| mouse monoclonal (L243) |
| In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences HLA-DR antibody (BD, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi |
| mouse monoclonal (G46-6) |
| In order to generate three different polarized macrophage and assess their immune function in an air-blood barrier co-culture, BD Biosciences HLA-DR antibody (BD Biosciences, 559866) was used in flow cytometry on human samples . J Tissue Eng Regen Med (2017) ncbi |
| mouse monoclonal (TU36) |
| In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences HLA-DR antibody (BD Biosciences, 555561) was used in flow cytometry on human samples . Nat Genet (2015) ncbi |
| mouse monoclonal (L243) |
| In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences HLA-DR antibody (BD Bioscience, L243) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi |
| mouse monoclonal (L243) |
| In order to characterize dendritic cell lipid content, function and phenotype due to mesothelioma tumor cell modulation, BD Biosciences HLA-DR antibody (BD Pharmingen, L243) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on African green monkey samples . J Infect Dis (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, L243) was used in flow cytometry on human samples (fig 3b). Front Immunol (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 1). Immunol Cell Biol (2015) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 2). Immunol Cell Biol (2015) ncbi |
| mouse monoclonal (G46-6) |
| In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi |
| mouse monoclonal (G46-6) |
| In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi |
| mouse monoclonal (L243) |
| In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences HLA-DR antibody (BD Bioscience, L243) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi |
| mouse monoclonal (L243) |
| In order to ascertain the impact of cell-intrinsic immunity on the latent reservoir of HIV, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig st3). AIDS (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, 559866) was used in flow cytometry on human samples . Alcohol (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD, Tu39) was used in flow cytometry on human samples . Hum Immunol (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (tbl 1). Exp Ther Med (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:5. Nat Commun (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 2). Blood (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4). Immunol Cell Biol (2015) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555558) was used in flow cytometry on human samples (fig 1). Methods Mol Biol (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555811) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2015) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi |
| mouse monoclonal (TU36) |
| BD Biosciences HLA-DR antibody (PharMingen, TU36) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (Becton Dickenson, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Clin Exp Allergy (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Blood (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Bioscience, G46) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to demonstrate that CPXV012 inhibits peptide transport by inhibiting ATP binding to the transporter associated with antigen processing, BD Biosciences HLA-DR antibody (BD Pharmingen, 347401) was used in immunoprecipitation on human samples and in western blot on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on African green monkey samples (fig s1). PLoS Pathog (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig s1b). Oncotarget (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to investigate the effects of Nucleofection on freshly isolated primary CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity, BD Biosciences HLA-DR antibody (Becton Dickinson Pharmingen, 555811) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Bioscience, clone L243) was used in flow cytometry on human samples . Mol Ther (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to develop methods to isolate inducible PMLC (HLA-DR(+)CD14(++)CD16(-) cells) and then characterize these cells, BD Biosciences HLA-DR antibody (BD Horizon, 561359) was used in flow cytometry on human samples . J Inflamm (Lond) (2014) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD Biosciences, Tu39) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6/L243) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi |
| mouse monoclonal (L243) |
| In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences HLA-DR antibody (BD Biosciences, G46-6/L243) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (Becton-Dickinson Pharmingen, L243) was used in flow cytometry on human samples . Nanomedicine (2014) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to discuss the importance of assessing immune competence in cancer patients, BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD, L243) was used in flow cytometry on human samples . Cytometry A (2014) ncbi |
| mouse monoclonal (G46-6) |
| In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BD Biosciences HLA-DR antibody (BD, G46-6) was used in flow cytometry on human samples (fig 4B). J Immunol (2014) ncbi |
| mouse monoclonal (L243) |
| BD Biosciences HLA-DR antibody (BD Biosciences, 347367) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi |
| mouse monoclonal (Tu39) |
| BD Biosciences HLA-DR antibody (BD, 555557) was used in flow cytometry on human samples at 1:200. PLoS ONE (2013) ncbi |
| mouse monoclonal (Tu39) |
| In order to investigate the thymus development, BD Biosciences HLA-DR antibody (BD, TU39) was used in immunohistochemistry on human samples . Development (2013) ncbi |
| mouse monoclonal (G46-6) |
| In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences HLA-DR antibody (BD, 560651) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi |
| mouse monoclonal (G46-6) |
| BD Biosciences HLA-DR antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples at 1:5. Microvasc Res (2012) ncbi |
| mouse monoclonal (L243) |
| In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, BD Biosciences HLA-DR antibody (BD, 347364) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi |
| mouse monoclonal (L243) |
| In order to determine the expression of CD39 in mouse and human T cells, BD Biosciences HLA-DR antibody (BD Biosciences, L243) was used in flow cytometry on human samples (fig 6). Blood (2007) ncbi |
Articles Reviewed
- Garcia Mesa Y, Xu H, Vance P, Gruenewald A, Garza R, Midkiff C, et al. Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. Antioxidants (Basel). 2021;10: pubmed publisher
- Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
- Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed publisher
- Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
- Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
- Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
- Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
- van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
- Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
- Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
- Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
- Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
- Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
- Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
- Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
- Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
- Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed publisher
- Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
- Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
- Hollmen M, Karaman S, Schwager S, Lisibach A, Christiansen A, Maksimow M, et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology. 2016;5:e1115177 pubmed
- Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
- Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
- Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
- Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
- Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
- Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed publisher
- Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
- Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
- Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
- Yeaman G, Asin S, Weldon S, Demian D, Collins J, Gonzalez J, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology. 2004;113:524-33 pubmed
- Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55:478-84 pubmed
- Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
- Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
- Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata Takeuchi M, et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int Immunol. 2002;14:545-54 pubmed
- Belge K, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536-42 pubmed
- Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
- Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
- Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
articles
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments